HCA Healthcare stock (US40412C1018): Largest US hospital operator by beds

HCA Healthcare, the largest for-profit hospital operator in the United States, manages more than 180 hospitals and approximately 2,400 ambulatory surgery centers, freestanding ERs, and physician clinics across 20 states and the UK. The company reported full-year 2025 revenue of $70.8 billion, up 7% from 2024, according to its annual report as of February 2026.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

HCA Healthcare: core business model

HCA Healthcare operates as an integrated healthcare delivery system, focusing on acute care hospitals, outpatient facilities, and related services. Its model emphasizes high-volume patient care in high-growth US markets like Florida, Texas, and Tennessee, where population growth drives demand. The company owns or operates 186 hospitals with over 49,000 licensed beds as of late 2025, per its 10-K filing as of February 2026.

Revenue primarily comes from providing medical and surgical services to patients covered by commercial insurance, Medicare, and Medicaid. HCA invests heavily in technology and facility expansions to improve efficiency and patient throughput. This vertically integrated approach includes owning surgery centers and imaging facilities, which generate higher margins than traditional inpatient care.

Main revenue and product drivers for HCA Healthcare

Inpatient services account for about 55% of revenue, driven by cardiology, orthopedics, and general surgery. Outpatient volumes, boosted by freestanding emergency rooms and ambulatory surgery centers, contribute another 35%. The remaining comes from physician practices and other ancillary services. For Q4 2025, admissions rose 4% year-over-year to 1.2 million, according to the earnings release as of February 2026.

Key growth drivers include an aging US population and rising elective procedures post-pandemic. HCA's focus on high-acuity cases, such as transplants and neurosurgery, supports premium pricing from insurers. The company also benefits from economies of scale in supply chain management, controlling costs for drugs and devices across its network.

Industry trends and competitive position

The US hospital sector faces pressures from labor shortages, rising costs, and payer mix shifts toward government programs. HCA differentiates through its scale, operating in Sun Belt states with favorable demographics and lower regulation. It holds about 5% of the national acute care market, ahead of rivals like Tenet Healthcare and Community Health Systems.

Trends like value-based care and consolidation favor large operators like HCA, which can invest in electronic health records and telehealth. The company's 2025 EBITDA margin of 20.8% outperformed the industry average of 15%, per S&P Global data as of March 2026.

Why HCA Healthcare matters for US investors

HCA Healthcare offers exposure to the $4.5 trillion US healthcare market, which grows 5-6% annually due to demographics and innovation. Listed on the NYSE, it provides retail investors access to defensive growth amid economic cycles, as healthcare demand remains steady. Its dividend yield of around 0.8% and history of share repurchases appeal to income-focused portfolios.

Main revenue and product drivers for HCA Healthcare

HCA derives most revenue from its US operations, with 93% from domestic facilities. Florida and Texas each contribute over 20% of total revenue, benefiting from migration and tourism-related care. International revenue from UK hospitals adds diversification but remains under 5%.

Conclusion

HCA Healthcare stands as a dominant player in US acute care, leveraging scale and geographic focus for steady growth. Recent financials show resilience in volumes and margins despite sector headwinds. Investors track its ability to navigate reimbursement changes and labor costs in coming quarters.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.